Mendelspod Podcast
The 21st is the Century of Biology. A radical advancement in the knowledge of basic biology and human disease is transforming our world. We interview the heroes beneath the headlines.
- Update frequency
- every 5 days
- Average duration
- 27 minutes
- Episodes
- 503
- Years Active
- 2014 - 2025
New Proteomics Technology Brings Unprecedented Sensitivity and Scale: Yuling Luo, CEO, Alamar Bio
Yuling Luo is a serial entrepreneur who has founded three significant companies in life science tools. Most recently, he is the founder and CEO of Alamar Biosciences which this year commercially laun…
Diagnostic Trends in 2024 with Mara Aspinall, Illumina Ventures
One might think the pandemic would have been good for diagnostic companies. So why the financial hangover?Mara Aspinal…
The Actionable Epigenome with Bret Barnes, Illumina
The genome has been the core focus of biomedical research for twenty years. Although the genome is prewritten and predetermined, much biology happens after it appears. One area is epigenomics, which …
Not All Prenatal Screens Are the Same: Jennifer Hoskovec, Billion to One
Not content to offer “me too” products, a new company in the prenatal arena, Billion to One (BTO), is reimagining prena…
Harvard's Marc Lipsitch on the New White House Policy Regulating Risky Pathogen Research
This week, we saw Dr. Anthony Fauci being grilled by an angry congress over, among other things, the origin of COVID-19, which is estimated killed at least 25 million people. He was asked about how …
Liquid Biopsy Goes Beyond Cancer: Diana Abdueva and Maggie Louie, Aqtual
A new precision medicine startup has launched that uses transcriptomic and epigenetic information to help with therapy for a wide range of chronic disorders. Hayward, California-based Aqtual emerged …
Cell Therapy Will Transform Medicine as We Know It, Says Jason Bock, CTMC
Today, we pursue an exciting area of medicine for the first time: cell therapy for solid tumors.Most, if not all, of o…
Two Industry Leaders on Dealing with the Growing Complexity of Genomic Cancer Data
The Clinical Knowledge Base (CKB) powered by The Jackson Laboratory (JAX) is a dynamic digital resource for interpreting complex cancer genomic profiles in the context of gene variant knowledge and p…
Single Cell Spatial Proteomics with Filip Karlsson, Pixelgen
A paper out this week in Nature Methods demonstrates a new technology which shows novel patterns of protein spatial polarization and co-localization in immune cells. The technology launched by Swedis…
The Precision Medicine Optimist: Damon Hostin, Illumina
Damon Hostin has had an active and exciting journey in genomic medicine. He’s now at Illumina, where his title is illuminative: Lead, Health System Market Access.A regular on the precision medicine…
An Ethics First Approach to Genetic Research and Drug Development with Sarah LeBaron von Baeyer
Sarah LeBaron von Baeyer studied anthropology at Yale. Today she serves as the Director of Ethics Engagement at the new…
How Do You Train Genomics AI? On Natural Selection Itself, Says VP of Illumina’s AI Lab, Kyle Farh
In today’s show, we talk with Kyle Fahr, the VP and Distinguished Scientist leading Illumina’s Artificial Intelligence Lab.
"We lack a way of training genomics AI as readily as you would for natural l…
The Pre-Symptomatic Space with Patrick Short, Sano Genetics
Today, we continue our look into the gap in the adoption of precision medicine. Why are those who need it not getting g…
Systemwide Implementation of Precision Medicine at UCHealth with David Kao
Through its Center for Personalized Medicine, the University of Colorado Health offers its 2.2 million patients some of…
Is this New Tech a Game Changer for Spatial Biology?
A new spatial biology company is promising to shake up the field. Last month, Curio Bioscience launched a new technolo…
Synthetic Biology in 2024 with John Cumbers
John Cumbers is back on the show to preview the annual SynBioBeta, the leading global conference for the synthetic biology crowd. This year’s show includes 18 tracks on AI, space, longevity, and DNA …
Illumina Scales Variant Calling and Genome Interpretation to Improve Gap in Genetic Testing with Sam Strom
Most of the news coming from Illumina has had to do with their leadership in the sequencing instrument space. What is lesser known is that they offer an end-to-end solution for the clinical lab, incl…
The Renaissance in DNA Synthesis Continues: Cosimo Ducani, CEO, Moligo
Today, we feature a new DNA synthesis company out of Sweden that is making a name with long, single-stranded DNA at sca…
Jennifer Wipf of Ginkgo Bioworks on RNA Therapeutics and Cell Therapy
The rise of RNA therapeutics and cell therapies promises to take us where we’ve never been in medicine. The growing understanding of RNA, mRNA, and circular RNA and their crucial roles in disease ha…
Precision Medicine for Dogs: Christina Lopes, OneHealth
Chapters:
0:00 Number one unmet medical need for dogs
6:25 Using “extra label” for cross species
12:57 Ideal for understan…